The vote is “truly a wake-up call for Novavax’s leadership” and “shareholders are clearly infuriated,” the activist investor says.
Browsing: Novavax
Shah Capital renews pressure on Novavax board, saying the biotech’s underperformance calls for a strategic sale to unlock value.
From Novavax to global equities, Raleigh, NC -based Shah Capital’s founder shares his investment philosophy and strategy
The newly approved vaccine targets multiple circulating variants, promising enhanced protection and availability across thousands of U.S. locations starting next week